• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用数据驱动的方法从中医药中寻找 COVID-19 的潜在治疗方法。

Identifying potential treatments of COVID-19 from Traditional Chinese Medicine (TCM) by using a data-driven approach.

机构信息

Shandong University of Traditional Chinese Medicine, Jinan, 250355, China; Marine Traditional Chinese Medicine Research Center, Qingdao Academy of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Qingdao, 266114, China.

Shandong University of Traditional Chinese Medicine, Jinan, 250355, China; Marine Traditional Chinese Medicine Research Center, Qingdao Academy of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Qingdao, 266114, China; Shandong Engineering and Technology Research Center of Traditional Chinese Medicine, Jinan, 250355, China.

出版信息

J Ethnopharmacol. 2020 Aug 10;258:112932. doi: 10.1016/j.jep.2020.112932. Epub 2020 May 4.

DOI:10.1016/j.jep.2020.112932
PMID:32376368
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7196535/
Abstract

ETHNOPHARMACOLOGICAL RELEVANCE

Traditional Chinese Medicine (TCM) has been widely used as an approach worldwide. Chinese Medicines (CMs) had been used to treat and prevent viral infection pneumonia diseases for thousands of years and had accumulated a large number of clinical experiences and effective prescriptions.

AIM OF THE STUDY

This research aimed to systematically excavate the classical prescriptions of Chinese Medicine (CM), which have been used to prevent and treat Pestilence (Wenbing, Wenyi, Shiyi or Yibing) for long history in China, to obtain the potential prescriptions and ingredients to alternatively treat COVID-19.

MATERIALS AND METHODS

We developed the screening system based on data mining, molecular docking and network pharmacology. Data mining and association network were used to mine the high-frequency herbs and formulas from ancient prescriptions. Virtual screening for the effective components of high frequency CMs and compatibility Chinese Medicine was explored by a molecular docking approach. Furthermore, network pharmacology method was used to preliminarily uncover the molecule mechanism.

RESULTS

574 prescriptions were obtained from 96,606 classical prescriptions with the key words to treat "Warm diseases (Wenbing)", "Pestilence (Wenyi or Yibing)" or "Epidemic diseases (Shiyi)". Meanwhile, 40 kinds of CMs, 36 CMs-pairs, 6 triple-CMs-groups existed with high frequency among the 574 prescriptions. Additionally, the key targets of SARS-COV-2, namely 3CL hydrolase (Mpro) and angiotensin-converting enzyme 2(ACE2), were used to dock the main ingredients from the 40 kinds by the LigandFitDock method. A total of 66 compounds components with higher frequency were docked with the COVID-19 targets, which were distributed in 26 kinds of CMs, among which Gancao (Glycyrrhizae Radix Et Rhizoma), HuangQin (Scutellariae Radix), Dahuang (Rhei Radix Et Rhizome) and Chaihu (Bupleuri Radix) contain more potential compounds. Network pharmacology results showed that Gancao (Glycyrrhizae Radix Et Rhizoma) and HuangQin (Scutellariae Radix) CMs-pairs could also interact with the targets involving in immune and inflammation diseases.

CONCLUSIONS

These results we obtained probably provided potential candidate CMs formulas or active ingredients to overcome COVID-19. Prospectively, animal experiment and rigorous clinic studies are needed to confirm the potential preventive and treat effect of these CMs and compounds.

摘要

民族药理学相关性

中药(TCM)已在全球范围内广泛应用。中医药(CMs)数千年来一直用于治疗和预防病毒性肺炎疾病,并积累了大量的临床经验和有效处方。

研究目的

本研究旨在系统挖掘中国古代防治瘟疫(温病、瘟疫、疫病或疫病)的经典方剂,获得潜在的防治 COVID-19 的方剂和成分。

材料和方法

我们开发了基于数据挖掘、分子对接和网络药理学的筛选系统。数据挖掘和关联网络用于从古代方剂中挖掘高频草药和方剂。通过分子对接方法探索高频 CMs 和配伍中药的有效成分虚拟筛选。此外,网络药理学方法用于初步揭示分子机制。

结果

从 96606 个古典方剂中,以关键词“温病”、“瘟疫”或“疫病”为关键词,共获得 574 个方剂。同时,574 个方剂中存在 40 种 CMs、36 种 CMs 对、6 种三 CMs 组,高频存在。此外,SARS-COV-2 的关键靶点,即 3CL 水解酶(Mpro)和血管紧张素转换酶 2(ACE2),用 LigandFitDock 方法对接 40 种 CMs 中的主要成分。共有 66 种化合物成分以较高的频率与 COVID-19 靶点对接,分布在 26 种 CMs 中,其中甘草(甘草)、黄芩(黄芩)、大黄(大黄)和柴胡(柴胡)含有更多的潜在化合物。网络药理学结果表明,甘草(甘草)和黄芩(黄芩)对 CMs 也可以与涉及免疫和炎症疾病的靶点相互作用。

结论

这些结果可能为克服 COVID-19 提供了潜在的候选 CMs 方剂或活性成分。前瞻性地,需要动物实验和严格的临床研究来证实这些 CMs 和化合物的潜在预防和治疗效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a809/7196535/a05245e2105b/gr9_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a809/7196535/162584d416f3/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a809/7196535/a258d6aa6fa5/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a809/7196535/79665f8323a5/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a809/7196535/3d2cf05f3477/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a809/7196535/4321a4057566/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a809/7196535/762eb0448ba5/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a809/7196535/92503f89f81e/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a809/7196535/8a48391a5044/gr7_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a809/7196535/2b0e24f085a4/gr8_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a809/7196535/a05245e2105b/gr9_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a809/7196535/162584d416f3/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a809/7196535/a258d6aa6fa5/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a809/7196535/79665f8323a5/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a809/7196535/3d2cf05f3477/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a809/7196535/4321a4057566/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a809/7196535/762eb0448ba5/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a809/7196535/92503f89f81e/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a809/7196535/8a48391a5044/gr7_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a809/7196535/2b0e24f085a4/gr8_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a809/7196535/a05245e2105b/gr9_lrg.jpg

相似文献

1
Identifying potential treatments of COVID-19 from Traditional Chinese Medicine (TCM) by using a data-driven approach.利用数据驱动的方法从中医药中寻找 COVID-19 的潜在治疗方法。
J Ethnopharmacol. 2020 Aug 10;258:112932. doi: 10.1016/j.jep.2020.112932. Epub 2020 May 4.
2
[Study on screening potential traditional Chinese medicines against 2019-nCoV based on Mpro and PLP].基于Mpro和PLP筛选抗2019新型冠状病毒潜在中药的研究
Zhongguo Zhong Yao Za Zhi. 2020 Mar;45(6):1219-1224. doi: 10.19540/j.cnki.cjcmm.20200216.401.
3
[Medication law and mechanism of traditional Chinese medicine in prevention and treatment of epidemic diseases: based on traditional Chinese medicine theory of cold pestilence].[中药防治疫病的用药规律及作用机制:基于中医寒疫理论]
Zhongguo Zhong Yao Za Zhi. 2022 Sep;47(17):4765-4777. doi: 10.19540/j.cnki.cjcmm.20220528.501.
4
[Study on medication regularity of traditional Chinese medicine in treatment of COVID-19 based on data mining].基于数据挖掘的中医治疗新型冠状病毒肺炎用药规律研究
Zhongguo Zhong Yao Za Zhi. 2020 Mar;45(6):1248-1252. doi: 10.19540/j.cnki.cjcmm.20200220.502.
5
[Analysis of medication regularity and pharmacodynamic characteristics of traditional Chinese medicine treatment in 444 severe cases of COVID-19].444例新冠肺炎重症病例中医治疗用药规律及药效学特征分析
Zhongguo Zhong Yao Za Zhi. 2020 Jul;45(13):3007-3012. doi: 10.19540/j.cnki.cjcmm.20200427.501.
6
In Silico Screening of Potential Chinese Herbal Medicine Against COVID-19 by Targeting SARS-CoV-2 3CLpro and Angiotensin Converting Enzyme II Using Molecular Docking.基于分子对接的针对 SARS-CoV-2 3CLpro 和血管紧张素转化酶 II 的新冠病毒潜在中草药的计算机筛选
Chin J Integr Med. 2020 Jul;26(7):527-532. doi: 10.1007/s11655-020-3476-x. Epub 2020 Jul 6.
7
Clinical data mining reveals Gancao-Banxia as a potential herbal pair against moderate COVID-19 by dual binding to IL-6/STAT3.临床数据挖掘揭示甘草-半夏可能通过双重结合 IL-6/STAT3 成为治疗中度 COVID-19 的一对草药。
Comput Biol Med. 2022 Jun;145:105457. doi: 10.1016/j.compbiomed.2022.105457. Epub 2022 Mar 26.
8
[Study on treatment of "cytokine storm" by anti-2019-nCoV prescriptions based on arachidonic acid metabolic pathway].基于花生四烯酸代谢途径的抗2019新型冠状病毒方剂治疗“细胞因子风暴”的研究
Zhongguo Zhong Yao Za Zhi. 2020 Mar;45(6):1225-1231. doi: 10.19540/j.cnki.cjcmm.20200224.405.
9
Network pharmacology and molecular docking analysis on molecular targets and mechanisms of Huashi Baidu formula in the treatment of COVID-19.基于网络药理学和分子对接的方法研究化湿败毒方治疗 COVID-19 的分子作用靶点及机制。
Drug Dev Ind Pharm. 2020 Aug;46(8):1345-1353. doi: 10.1080/03639045.2020.1788070. Epub 2020 Jul 8.
10
[Analysis of traditional Chinese medicine from patent information sharing platform of coronavirus disease 2019 (COVID-19)].[基于2019冠状病毒病(COVID-19)专利信息共享平台的中医药分析]
Zhongguo Zhong Yao Za Zhi. 2020 Jul;45(13):3001-3006. doi: 10.19540/j.cnki.cjcmm.20200330.501.

引用本文的文献

1
Synergistic coupling of ultrasonic cavitation with tailored deep eutectic solvent systems for intensified extraction of Scutellaria Radix flavonoids: Modelling and optimization by genetic algorithm.超声空化与定制的低共熔溶剂体系协同耦合用于强化黄芩黄酮提取:基于遗传算法的建模与优化
Ultrason Sonochem. 2025 Aug;119:107386. doi: 10.1016/j.ultsonch.2025.107386. Epub 2025 May 15.
2
The Protective Effects of Modified Dachaihu Decoction against LPS-induced Acute Lung Injury Modulating PI3K/Akt Signalling Pathway.加味大柴胡汤对脂多糖诱导的急性肺损伤的保护作用——调节PI3K/Akt信号通路
Comb Chem High Throughput Screen. 2025;28(5):755-767. doi: 10.2174/0113862073282311240226113714.
3

本文引用的文献

1
[Rapid establishment of traditional Chinese medicine prevention and treatment of 2019-nCoV based on clinical experience and molecular docking].基于临床经验和分子对接快速建立中医药防治新型冠状病毒肺炎方案
Zhongguo Zhong Yao Za Zhi. 2020 Mar;45(6):1213-1218. doi: 10.19540/j.cnki.cjcmm.20200206.501.
2
Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention Programs.中医可否用于预防 2019 年冠状病毒病(COVID-19)?对历史经典、研究证据和当前预防方案的回顾。
Chin J Integr Med. 2020 Apr;26(4):243-250. doi: 10.1007/s11655-020-3192-6. Epub 2020 Feb 17.
3
Explainable machine learning model and nomogram for predicting the efficacy of Traditional Chinese Medicine in treating Long COVID: a retrospective study.
用于预测中医治疗新冠后综合征疗效的可解释机器学习模型和列线图:一项回顾性研究
Front Med (Lausanne). 2025 Mar 13;12:1529993. doi: 10.3389/fmed.2025.1529993. eCollection 2025.
4
Advancing the Identification of Bioactive Molecules and the Construction of a Synergistic Drug Delivery System in Combating Lung Injury.推进生物活性分子的鉴定以及构建协同药物递送系统以对抗肺损伤。
Adv Sci (Weinh). 2025 May;12(18):e2407802. doi: 10.1002/advs.202407802. Epub 2025 Mar 17.
5
Role of innate immunity in SARS-CoV-2 infection.固有免疫在2019冠状病毒病感染中的作用。
Biosaf Health. 2023 Sep 9;5(5):280-288. doi: 10.1016/j.bsheal.2023.08.005. eCollection 2023 Oct.
6
AI empowering traditional Chinese medicine?人工智能赋能中医?
Chem Sci. 2024 Sep 23;15(41):16844-86. doi: 10.1039/d4sc04107k.
7
Screening potential treatments for mpox from Traditional Chinese Medicine by using a data-driven approach.运用数据驱动的方法从中医药中筛选猴痘的潜在治疗方法。
Medicine (Baltimore). 2023 Sep 15;102(37):e35116. doi: 10.1097/MD.0000000000035116.
8
identification of natural compounds against SARS-CoV-2 main protease from Chinese herbal medicines.从中药中鉴定抗新型冠状病毒主要蛋白酶的天然化合物
Future Sci OA. 2023 Jun 14;9(7):FSO873. doi: 10.2144/fsoa-2023-0055. eCollection 2023 Aug.
9
Potential herb‒drug interactions between anti-COVID-19 drugs and traditional Chinese medicine.抗新冠病毒药物与中药之间潜在的药草-药物相互作用。
Acta Pharm Sin B. 2023 Jun 5;13(9):3598-637. doi: 10.1016/j.apsb.2023.06.001.
10
Advances in the study of myeloid-derived suppressor cells in infectious lung diseases.感染性肺病中髓源性抑制细胞研究进展。
Front Immunol. 2023 Mar 29;14:1125737. doi: 10.3389/fimmu.2023.1125737. eCollection 2023.
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.
中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征:描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
4
The characteristics and regularities of cardiac adverse drug reactions induced by Chinese materia medica: A bibliometric research and association rules analysis.中药致心脏不良反应的特点及规律:基于文献计量学研究和关联规则分析。
J Ethnopharmacol. 2020 Apr 24;252:112582. doi: 10.1016/j.jep.2020.112582. Epub 2020 Jan 21.
5
Application of Chinese Medicine in Acute and Critical Medical Conditions.中医在急症及危重症中的应用。
Am J Chin Med. 2019;47(6):1223-1235. doi: 10.1142/S0192415X19500629. Epub 2019 Sep 10.
6
Hepatoprotective effects of a traditional Chinese medicine formula against carbon tetrachloride-induced hepatotoxicity in vivo and in vitro.一种中药配方对体内和体外四氯化碳诱导的肝毒性的保肝作用。
Biomed Pharmacother. 2019 Sep;117:109190. doi: 10.1016/j.biopha.2019.109190. Epub 2019 Jul 4.
7
Network pharmacology study reveals energy metabolism and apoptosis pathways-mediated cardioprotective effects of Shenqi Fuzheng.网络药理学研究揭示了参芪扶正的能量代谢和细胞凋亡途径介导的心脏保护作用。
J Ethnopharmacol. 2018 Dec 5;227:155-165. doi: 10.1016/j.jep.2018.08.029. Epub 2018 Aug 23.
8
System Pharmacology-Based Dissection of the Synergistic Mechanism of Huangqi and Huanglian for Diabetes Mellitus.基于系统药理学剖析黄芪与黄连治疗糖尿病的协同机制
Front Pharmacol. 2017 Oct 5;8:694. doi: 10.3389/fphar.2017.00694. eCollection 2017.
9
Toward Understanding the Cold, Hot, and Neutral Nature of Chinese Medicines Using in Silico Mode-of-Action Analysis.基于计算机模拟的中药“四气”作用机制分析方法研究进展。
J Chem Inf Model. 2017 Mar 27;57(3):468-483. doi: 10.1021/acs.jcim.6b00725. Epub 2017 Mar 16.
10
Tianfoshen oral liquid: a CFDA approved clinical traditional Chinese medicine, normalizes major cellular pathways disordered during colorectal carcinogenesis.天佛参口服液:一种经中国国家食品药品监督管理总局批准的临床用传统中药,可使结直肠癌发生过程中紊乱的主要细胞通路恢复正常。
Oncotarget. 2017 Feb 28;8(9):14549-14569. doi: 10.18632/oncotarget.14675.